Dr. Ismail attended both medical school and residency in Alberta finishing residency in 1999. He worked initially at the University of Alberta and the University of Calgary for 6 years in an academic hospital setting. He then took a sabbatical at the University of Toronto and did a fellowship in Neuropsychiatry at Sunnybrook Health Sciences Centre. Subsequently, Dr. Ismail took a faculty appointment at the University of Toronto at the Centre for Addiction in Mental Health. In addition to running an inpatient teaching team, Dr. Ismail was head of the CAMH Memory Clinic. After 6 years in Toronto he returned to the University of Calgary at the Cumming School of Medicine in August 2011. He is an Associate Professor of Psychiatry, Neurology, and Epidemiology at the Hotchkiss Brain Institute. He is working with both adult and geriatric patients across the neuropsychiatric spectrum. Dr. Ismail’s research interests revolve extensively around the interface between cognition and neuropsychiatric symptoms including studies of clinical psychopharmacology, epidemiology, cognitive and neuropsychiatric screening, rating scale development, adverse drug reaction surveillance studies, and neuroimaging biomarker studies of neuropsychiatric illnesses. He is certified in Behavioural Neurology and Neuropsychiatry by the United Council for Neurologic Subspecialties, is a member of the Mathison Centre for Mental Health Research & Education, and the Ron and Rene Ward Centre for Healthy Brain Aging Research. Dr. Ismail is an author on the most recent CANMAT depression treatment guidelines and the 2017 CPA Clinical Practice Guidelines for Schizophrenia.